The Contribution of Oxidative Stress to NF1-Altered Tumors
Antioxidants · 04.08.2023 · 12 (8) · 1557
DOI: 10.3390/antiox12081557 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 04.08.2023. Verfasst von Elisabetta Kuhn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The neurofibromatosis-1 gene (NF1) was initially characterized because its germline mutation is responsible for an inherited syndromic disease predisposing tumor development, in particular neurofibromas but also various malignancies. Recently, large-scale tumor sequencing efforts have demonstrated NF1 as one of the most frequently mutated genes in human cancer, being mutated in approximately 5–10% of all tumors, especially in malignant peripheral nerve sheath tumors and different skin tumors. NF1 acts as a tumor suppressor gene that encodes neurofibromin, a large protein that controls neoplastic transformation through several molecular mechanisms. On the other hand, neurofibromin loss due to NF1 biallelic inactivation induces tumorigenic hyperactivation of Ras and mTOR signaling pathways. Moreover, neurofibromin controls actin cytoskeleton structure and the metaphase–anaphase transition. Consequently, neurofibromin deficiency favors cell mobility and proliferation as well as chromosomal instability and aneuploidy, respectively. Growing evidence supports the role of oxidative stress in NF1-related tumorigenesis. Neurofibromin loss induces oxidative stress both directly and through Ras and mTOR signaling activation. Notably, innovative therapeutic approaches explore drug combinations that further increase reactive oxygen species to boost the oxidative unbalance of NF1-altered cancer cells. In our paper, we review NF1-related tumors and their pathogenesis, highlighting the twofold contribution of oxidative stress, both tumorigenic and therapeutic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.
- Pathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- Medical Genetics Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- Department of Neurorehabilitation Sciences, Casa di Cura Igea, 20144 Milan, Italy.
- Human Pathology and Molecular Pathology, TOMA Advanced Biomedical Assays S.p.A., 21052 Busto Arsizio, Italy.
ORCID-Profile: Elisabetta Kuhn, Federica Natacci, Donatella Gambini
Zitieren
APA
Kuhn, E., Natacci, F., Corbo, M., Pisani, L., Ferrero, S., Bulfamante, G., & Gambini, D. (2023). The Contribution of Oxidative Stress to NF1-Altered Tumors. Antioxidants, 12(8), 1557. https://doi.org/10.3390/antiox12081557
Vancouver
Kuhn E, Natacci F, Corbo M, Pisani L, Ferrero S, Bulfamante G, et al. The Contribution of Oxidative Stress to NF1-Altered Tumors. Antioxidants. 2023;12(8):1557. doi:10.3390/antiox12081557
BibTeX
@article{Kuhn2023,
author = {Kuhn, Elisabetta and Natacci, Federica and Corbo, Massimo and Pisani, Luigi and Ferrero, Stefano and Bulfamante, Gaetano and Gambini, Donatella},
title = {The Contribution of Oxidative Stress to NF1-Altered Tumors},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {8},
pages = {1557},
doi = {10.3390/antiox12081557}
}
EUVIMED